HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lichen planus-type chronic graft-versus-host disease complicated by mucous membrane pemphigoid with positive anti-BP180/230 and scleroderma-related autoantibodies followed by reduced regulatory T cell frequency.

AuthorsTakaaki Hanafusa, Hiroaki Azukizawa, Megumi Nishioka, Atsushi Tanemura, Hiroyuki Murota, Hisao Yoshida, Emiko Sato, Yoshiko Hashii, Keiichi Ozono, Hiroshi Koga, Takashi Hashimoto, Ichiro Katayama
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2012 Jan-Feb Vol. 22 Issue 1 Pg. 140-2 ISSN: 1167-1122 [Print] France
PMID22217601 (Publication Type: Case Reports, Letter)
Chemical References
  • Autoantibodies
  • Autoantigens
  • Carrier Proteins
  • Cytoskeletal Proteins
  • DST protein, human
  • Dystonin
  • Immunosuppressive Agents
  • Membrane Glycoproteins
  • Nerve Tissue Proteins
  • Non-Fibrillar Collagens
  • Tacrolimus
Topics
  • Adolescent
  • Autoantibodies (blood)
  • Autoantigens (immunology)
  • Carrier Proteins
  • Chronic Disease
  • Cytoskeletal Proteins
  • Dystonin
  • Graft vs Host Disease (complications, drug therapy, immunology)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Lichen Planus (complications, pathology)
  • Lymphocyte Count
  • Male
  • Membrane Glycoproteins (immunology)
  • Mouth Mucosa (pathology)
  • Nerve Tissue Proteins
  • Non-Fibrillar Collagens (immunology)
  • Pemphigoid, Bullous (complications, drug therapy, immunology)
  • Peripheral Blood Stem Cell Transplantation (adverse effects)
  • T-Lymphocytes, Regulatory
  • Tacrolimus (therapeutic use)
  • Collagen Type XVII

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: